Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

doxorubicin liposome

Known as: pegylated liposomal doxorubicin, Liposomal Doxorubicin, doxorubicin liposomal 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background:Pembrolizumab (P) is an anti-PD-1 antibody that blocks the interaction between programmed cell death protein 1 (PD-1… Expand
  • table 1
  • table 2
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
BACKGROUND Mesenchymal/metaplastic breast cancers (MpBCs) are often triple-negative (TNBC), and chemo-refractory, and can harbor… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2014
2014
Abstract Brain metastases (BM) can affect up to 45 % of a high-risk breast cancer (BC) population. Liposomal doxorubicin (LD… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2013
2013
BACKGROUND Despite improvement with intensive multi-agent chemotherapy, 2-year progression-free survival (PFS) rates for adults… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2011
2011
Stealth liposomes form an important subset of liposomes, demonstrating prolonged circulation half-life and improved safety in… Expand
Is this relevant?
2010
2010
BackgroundPlatinum-based combinations are the standard second-line treatment for platinum-sensitive ovarian cancer (OC). This… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2008
2008
Purpose: To determine the critical thermal dosimetry and relative efficacy for RF ablation combined with external beam radiation… Expand
Is this relevant?
2006
2006
5006 Background: Bevacizumab (BV), a recombinant, humanized monoclonal antibody directed against vascular endothelial growth… Expand
Is this relevant?
2005
2005
BACKGROUND Previous studies have shown that pegylated liposomal doxorubicin (LD) is effective in the treatment of relapsing or… Expand
Is this relevant?
2002
2002
BACKGROUND Both liposomal doxorubicin (LD) and docetaxel (D) have a broad range of activity against solid tumors, including… Expand
Is this relevant?